Show simple item record

dc.contributor.authorAli, Adnan
dc.contributor.authorHoyle, Alex P
dc.contributor.authorMistry, H
dc.contributor.authorClarke, Noel W
dc.date.accessioned2018-06-30T14:08:27Z
dc.date.available2018-06-30T14:08:27Z
dc.date.issued2018-05-19
dc.identifier.citationImportance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer. 2018, BJU Inten
dc.identifier.issn1464-410X
dc.identifier.pmid29777564
dc.identifier.doi10.1111/bju.14400
dc.identifier.urihttp://hdl.handle.net/10541/621078
dc.description.abstractTo determine the prognostic relevance of non-regional lymph node (NRLN) metastases presenting synchronously with bone metastases in metastatic prostate cancer (mPCa) for guiding treatment decisions based on oligometastatic definitions.
dc.language.isoenen
dc.rightsArchived with thanks to BJU internationalen
dc.titleImportance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.en
dc.typeArticleen
dc.contributor.departmentGenito-urinary cancer research group, Division of Cancer Sciences, Manchester Cancer Research Centre, University of Manchesteren
dc.identifier.journalBJU Internationalen
html.description.abstractTo determine the prognostic relevance of non-regional lymph node (NRLN) metastases presenting synchronously with bone metastases in metastatic prostate cancer (mPCa) for guiding treatment decisions based on oligometastatic definitions.


This item appears in the following Collection(s)

Show simple item record